Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. A randomized controlled trial in patients older than 59 years

JAMA

Volumn 281, Issue 1, 1999, Pages 39-45

  Reynolds III, Charles F ^a   Frank, Ellen ^a   Perel, James M ^a   Imber, Stanley D ^a   Cornes, Cleon ^a   Miller, Mark D ^a   Mazumdar, Sati ^a   Houck, Patricia R ^a   Dew, Mary Amanda ^a   Stack, Jacqueline A ^a   Pollock, Bruce G ^a   Kupfer, David J ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NORTRIPTYLINE;

ADULT; AGED; AGING; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RISK ASSESSMENT; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0033528101     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.1.39     Document Type: Article

References (38)

1. Beekman AT, Deeg DJ, van Tilburg T, et al. Major and minor depression in later life: a study of prevalence and risk factors. J Affect Disord. 1995;36:65-75.
2. Borson S, Barnes RA, Kukull WA, et al. Symptomatic depression in elderly medical outpatients, I: prevalence, demography, and health service utilization. J Am Geriatr Soc. 1986;34:341-347.
3. Blazer D. Depression in the elderly. W Engl J Med. 1989;320:164-166.
4. Unutzer J, Patrick DL, Simon G, et al. Depressive symptoms and the cost of health services in HMO patients aged 65 years and older: a 4-year prospective study. JAMA. 1997;277:1618-1623.
5. Conwell Y. Suicide in elderly patients. In: Schneider LS, Reynolds CF, Lebowitz BD, eds. Diagnosis and Treatment of Depression in Late Life. Washington, DC: American Psychiatric Press Inc: 1996:397-418.
6. Rovner BW. Depression and increased risk of mortality in the nursing home patient. Am J Med. 1993; 94(suppl):19S-22S.
7. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA. 1993;270:1819-1825.
8. NIH Consensus Development Panel on Depression in Late Life. Diagnosis and treatment of depression in late life. JAMA. 1992;268:1018-1024.
9. Murray CJL, Lopez AD. The Global Burden of Disease. Boston, Mass: World Health Organization and Harvard University Press: 1996.
10. Reynolds CF, Frank E, Kupfer DJ, et al. Treatment outcome in recurrent major depression: a post-hoc comparison of elderly ("young old") and midlife patients. Am J Psychiatry. 1996;153:1288-1292.
11. Little JT, Reynolds CF, Dew MA, et al. How common is resistance to treatment in recurrent, nonpsychotic geriatric depression? Am J Psychiatry. 1998; 155:1035-1038
12. Klerman CL, Weissman MM, Rounsaville BJ, Chevron E. Interpersonal Psychotherapy of Depression. New York, NY: Academic Press and Basic Books Inc; 1984.
13. Murphy E. The prognosis of depression in old age. Br J Psychiatry. 1983;142:111-119.
14. Post F, Benson DF, Blumer D. eds, Psychiatric Aspects of Neurologic Disease. New York, NY: Grune & Stratton Inc; 1998:99.
15. Reynolds CF, Frank E, Dew MA, et al. The challenge of treatment in 70+ year olds with major depression: excellent short-term but brittle long-term response. Am J Geriatr Psychiatry. In press.
16. Zis AP, Grof P. Webster M. Predictors of relapse in recurrent affective disorders. Psychopharmacol Bull. 1980;16:47-49.
17. Keller MB, Lavori PW, Collins CE, Klerman GL. Predictors of relapse in major depressive disorder. JAMA. 1983;250:3299-3304.
18. Angst J, ed. Classification and Prediction of Outcome of Depression. Berlin, Germany: Springer-Verlag; 1974.
19. Frank E, Kupfer DJ, Perel JM, et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry. 1990;47:1093-1099.
20. Spitzer RL. Schedule for Affective Disorders and Schizophrenia-Lifetime Version (SADS-L). New York: New York State Psychiatric Institute; 1978.
21. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
22. Folstein MF, Folstein SW, McHugh PR. "Minimental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
23. Stack JA, Paradis CF, Reynolds CF, et al. Does recruitment method make a difference? effects on protocol retention and treatment outcome in elderly depressed patients. J Psychiatry Res. 1995;56:17-24.
24. Fleiss J Design and Analyses of Clinical Experiments. New York, NY: John Wiley & Sons Inc; 1986: 46-51.
25. Reynolds CF, Schneider LS, Lebowitz BD, Kupfer DJ. Treatment of depression in elderly patients: guidelines for primary care. In: Schneider LS, Reynolds CF, Lebowitz BD, Friedhoff AJ, eds. Diagnosis and Treatment of Depression in Late-Life: Results of the NIH Consensus Development Conference. Washington, DC: American Psychiatric Press lnc; 1994:463-490.
26. Foglia JP, Stiller RL, Perel JM. The measurement of plasma nortriptyline and its isomeric 10-OH metabolites. Clin Chem. 1987;33:1024.
27. Beck AT, Ward CH, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
28. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment scale: a procedure for measuring over-all severity of psychiatric disturbance. Arch Gen Psychiatry. 1976;33:766-771.
29. Asberg M. Dose effects of antidepressant medication in different populations. J Affect Disord. 1986; 2(suppl):S1-S67.
30. Wagner EF, Frank E, Steiner SC. Discriminating maintenance treatments for recurrent depression: development and implementation of a rating scale. J Psychother Pract Res. 1992;22:281-291.
31. Perel JM. Geropharmacokinetics of therapeutics, toxic effects, and compliance. In: Schneider LS, Reynolds CF, Lebowitz BD, Friedhoff AJ, eds. Diagnosis and Treatment of Depression in Late-Life: Results of the NIH Consensus Development Conference. Washington, DC: American Psychiatric Press Inc; 1994:245-257.
32. Williamson GM, Schulz R. Relationship orientation, quality of prior relationship, and distress among caregivers of Alzheimer's patients. Psychol Aging. 1990; 5:502-510.
33. Miller MD, Paradis CF, Houck PR, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. J Psychiatr Res. 1992;41:237-248.
34. Georgotas A, McCue RE, Cooper TB, Nagachandran N, Chang I. How effective and safe is continuation therapy in elderly depressed patients? factors affecting relapse rate. Arch Gen Psychiatry. 1988;45:929-932.
35. Old Age Depression Interest Group (OADIG). How long should the elderly take antidepressants? a double-blind, placebo-controlled study of continuation/prophylaxis therapy with dothiepin. Br J Psychiatry. 1993;162:175-182.
36. Georgotas A, McCue RE, Cooper TB. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. Arch Gen Psychiatry. 1989;46:783-786.
37. Flint A, Rifat S. Recurrence following discontinuation of maintenance antidepressant medication for first episode geriatric depression. Paper presented at: The 1998 American Association for Geriatric Psychiatry; March 8, 1998; San Diego, Calif.
38. Lebowitz BD, Pearson JL, Schneider LS, et al. Diagnosis and treatment of depression in late-life: consensus statement update. JAMA. 1997;278:1186-1190.